VIR VIR BIOTECHNOLOGY
Health Care · Russell 2000
Next earnings: not announced yet
What 11 analyst firms say about VIR BIOTECHNOLOGY: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
9 rated views · 11 analyst/firm records · 11 firms
Radar score
- Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8064
- Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8048
Recent analyst activity · last 90 days
Our tracked history has 9 reports on VIR from 7 analyst firms in the last 90 days (11 firms in the past year).
Comparing each firm's latest target with its previous one: 1 raised its price target, 1 lowered it and 3 left it unchanged.
No firm's latest available rating differs from its previous one.
Latest observed target change: Needham raised its target from $18.00 (set 15 Sep 2026) to $20.00 on 5 Nov 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Barclays | Etzer Darout | Buy | 8 Oct 2026 | 30.00 USD |
| Evercore ISI | Cory Kasimov | Buy | 8 Jun 2026 | 22.00 USD |
| Goldman Sachs | Paul K Choi | Buy | 25 Jun 2026 | 21.00 USD |
| H.C. Wainwright | Patrick R. Trucchio | Buy | 7 Oct 2026 | 22.00 USD |
| Leerink Partners | Roanna Ruiz | Buy | 1 Sep 2026 | 17.00 USD |
| Morgan Stanley | Michelle Gilson | — | 6 Aug 2026 | 25.00 USD |
| Needham | Joseph R Stringer | Buy | 15 Sep 2026 | 18.00 USD |
| Raymond James | Sean Mccutcheon | Buy | 28 Sep 2026 | 19.00 USD |
| TD Cowen | Philip M Nadeau | Buy | 15 Jun 2026 | — |
| Weiss Ratings | Unnamed analyst | — | 2 Oct 2026 | — |
| Data feed RESEARCH | Research Team | Sell | 6 Oct 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 03:01 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.